DUBLIN–(BUSINESS WIRE)–The “Global Lab Automation in Drug Discovery Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering.
The global Lab automation in the drug discovery market is expected to register a CAGR of 5% during the forecast period 2021 – 2026. An automated system coupled with modern pharma has a significant impact on human life.
Key Highlights
- Automated systems, such as high throughput screening operations, compound repositories, and chemistry labs, have become prevalent in core labs and popular in academic environments. The extent of automation required is dependent on the nature of the task to be performed, the need for processing, and the amount of human intervention.
- Automation tools were able to process concurrent requests in real-time and were responsible for a marked improvement in productivity and throughput. They have greatly helped clinical and pre-clinical studies by developing, optimizing, and streamlining the workflow; researchers can achieve greater efficiency within a shorter period.
- North America has been the most significant contributor to growth in this market due to high levels of health awareness, significant R&D firms, and an emphasis on optimizing workflows by minimizing human intervention.
- The pandemic has also put enormous pressure on laboratories – from increased testing volumes and turnaround time to biosafety, workforce planning, and social distancing within the lab. As of December 2020, the total amount of testing across the industry was 245% of the baseline. Routine testing, which saw a drop of 66% in the pandemic’s early days, is already over 100% of pre-pandemic baseline levels (in the U.S.), while COVID-19 and routine testing volume combined are combined under 250% of baseline. Industry experts predict a substantial COVID-19 test and an increase in susceptibility antibody testing as the number of vaccinated people increases from 2021 to 2022. Automation plays a vital role in addressing staff shortages, allowing valuable resources to focus on high-value clinical tasks, especially during the COVID-19 pandemic.
Key Market Trends
Automated Liquid Handlers Equipment Account for the Largest Market Share
- Liquid handlers are usually employed in biochemical and chemical laboratories. Automated liquid handling robots help in dispensing samples and other liquids in laboratories. Automated liquid handlers minimize run times and maximize accuracy. Moreover, liquid handlers can operate across a wide range of volumes, extending into nanolitres, thus proving their usefulness in dispensing operations.
- Leading companies have set the benchmark for developing automated liquid handlers and are constantly investing in developing premium products to increase productivity effectively. The evolution of the liquid handlers, capable of handling minute volumes of liquids, has contributed to the rapid development of modular lab automation systems in the market.
- According to the Robotic Industries Association, the life science sector has the third-highest growth in industrial robots, in terms of automated liquid handlers, automated plate handlers, robotic arms, and others, to meet the demand.
- According to Parker, one of the trends in life science robotics is fluidics getting more straightforward in robotic analyzers. This trend arose because clinical laboratories and hospitals cannot afford an instrument to go down when critical samples are involved. Certain robotic systems with 50 needles on the end of a dispensing unit and lots of tubing increasingly use special valve manifolds that eliminate the need for tubing and result in less chance for failure. The manifolds minimize the chance of leakage.
Market Dynamics
Factors Driving the Market
- Technological Innovations Leading to Device Miniaturization and Increased Throughput
Factors Restraining the Market
- Slower Rate of Adoption in Small and Medium Scale Labs
Key Topics Covered:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
5 TECHNOLOGY OVERVIEW
6 DIFFERENT EQUIPMENT IN LAB AUTOMATION
7 MARKET SEGMENTATION
8 COMPETITIVE INTELLIGENCE
9 COMPETITIVE LANDSCAPE
9.1 Company Profiles*
9.1.1 Thermo Fisher Scientific
9.1.2 Beckman Coulter
9.1.3 Hudson Robotics
9.1.4 Becton Dickinson
9.1.5 Synchron Lab Automation
9.1.6 Agilent Technologies
9.1.7 Siemens Healthcare
9.1.8 Tecan Group Ltd
9.1.9 Perkinelmer
9.1.10 Bio-Rad
9.1.11 Roche Holding AG
9.1.12 Eppendorf AG
9.1.13 Shimadzu
9.1.14 Aurora Biomed
10 FUTURE OUTLOOK OF THE LAB AUTOMATION IN DRUG DISCOVERY MARKET
For more information about this report visit https://www.researchandmarkets.com/r/lxelwa
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
